Form 4: Nurix Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Christine Ring, Chief Legal Officer of Nurix Therapeutics, Inc., sold 16,589 shares of common stock on August 3, 2026 for $23.05 per share.
Summary
- Option exercise/conversion: acquired 5,787 Common Stock at $8.72 ($50,463) on August 3, 2026; holds 25,699 after (Direct).
- Open-market sale: disposed of 16,589 Common Stock at $23.05 ($382,358) on August 3, 2026; holds 9,110 after (Direct).
- Option exercise/conversion: disposed of 5,787 Employee Stock Option (right to buy) on August 3, 2026; holds 122,824 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $382,358 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Christine Ring — Officer (Chief Legal Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Option exercise/conversion | Common Stock | 5,787 | $9 | $50.5K | 25,699 |
| 2026-08-03 | Open-market sale | Common Stock | 16,589 | $23 | $382.4K | 9,110 |
| 2026-08-03 | Option exercise/conversion | Employee Stock Option (right to buy) | 5,787 | — | — | 122,824 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Option exercise/conversion (5,787 shares) |
| 2026-08-03 | Open-market sale (16,589 shares) |
| 2026-08-03 | Option exercise/conversion (5,787 shares) |
Keywords
insider transaction, Form 4, NRIX, Nurix Therapeutics, Inc., bearish, Christine Ring
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.